Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human SOCS2 Antibodies:
anti-Mouse (Murine) SOCS2 Antibodies:
anti-Rat (Rattus) SOCS2 Antibodies:
Go to our pre-filtered search.
Human Polyclonal SOCS2 Primary Antibody for WB - ABIN967065
Greenhalgh, Bertolino, Asa, Metcalf, Corbin, Adams, Davey, Nicola, Hilton, Alexander: Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). in Molecular endocrinology (Baltimore, Md.) 2002
Show all 4 Pubmed References
Human Polyclonal SOCS2 Primary Antibody for ELISA, WB - ABIN269520
Ransome, Turnley: Analysis of neuronal subpopulations in mice over-expressing suppressor of cytokine signaling-2. in Neuroscience 2005
Show all 8 Pubmed References
Human Polyclonal SOCS2 Primary Antibody for IF (p), IHC (p) - ABIN736028
Zhu, Dai, Han, He, Mo, Chen, Chen, Wu, Yang, Jiang, Chen, Sun, Zhong: Expression of SOCSs in human prostate cancer and their association in prognosis. in Molecular and cellular biochemistry 2013
Show all 3 Pubmed References
Human Polyclonal SOCS2 Primary Antibody for ELISA, WB - ABIN563827
Hamilton, Lin, Wang, Knowlton: Effect of ovariectomy on cardiac gene expression: inflammation and changes in SOCS gene expression. in Physiological genomics 2008
The upregulation of SOCS-1 (show SOCS1 Antibodies) and SOCS-2 by cortisol may be playing a key role in suppressing cytokine signaling and the associated inflammatory response.
SOCS-1 (show SOCS1 Antibodies), SOCS-2, and SOCS-3 (show SOCS3 Antibodies) proteins may directly or indirectly, have important roles in development and pathogenesis of papillary thyroid cancer
Despite of the key role of SOCS2 in the regulation of GH receptor (show GHR Antibodies) signaling, study did not find any significant association between SOCS2 polymorphisms and acromegaly.
The induction of a tolerogenic phenotype in DCs by NPs (show NPS Antibodies) was mediated by the AhR (show AHR Antibodies)-dependent induction of Socs2, which resulted in inhibition of nuclear factor kappaB activation and proinflammatory cytokine production (properties of tolerogenic DCs).
Long-term palmitate treatment up-regulates SOCS2 and reduces PI3K (show PIK3CA Antibodies) activity, thereby impairing glucose stimulated insulin (show INS Antibodies) secretion.
Targeting of SOCS2 by miR (show MLXIP Antibodies)-194 resulted in derepression of the oncogenic kinases FLT3 (show FLT3 Antibodies) and JAK2 (show JAK2 Antibodies), leading to enhanced ERK (show EPHB2 Antibodies) and STAT3 (show STAT3 Antibodies) signaling.
Single-cell RNA sequencing reveals enrichment of homeostatic modules in monocytes and dendritic cells from human metastatic melanoma. Suppressor-of-cytokine-2 (SOCS2) protein, a conserved program transcript, is expressed by mononuclear phagocytes infiltrating primary melanoma and is induced by IFNgamma.
this study shows that IL-7 (show IL7 Antibodies) induces the expression of SOCS2 through the JAK (show JAK3 Antibodies)/STAT-5 (show STAT5A Antibodies) pathway and that SOCS2 interacts with CD127 (show IL7R Antibodies) in early endosomes and direct the receptor complex to the proteasome for degradation
Overexpression of SOCS2 inverted these phenotypes generated by hsv2-miR (show MLXIP Antibodies)-H9-5p, indicating the potential roles of SOCS2 in Hsv2-miR (show MLXIP Antibodies)-H9-5p-driven metastasis in lung cancers. The results highlighted that Hsv2-miR (show MLXIP Antibodies)-H9-5p regulated and contributed to bone metastasis of lung cancers. We proposed that Hsv2-miR (show MLXIP Antibodies)-H9-5p could be used as a potential target in lung cancer therapy
Overexpression of SOCS-2 is associated with hepatocellular carcinoma.
focus on SOCS2 and review its biological function as well as its implication in pathological processes
SOCS2 deletion had no effect on total dendrite length, number of dendritic segments, number of branch points or total dendritic spine density but increased the number of mature "mushroom" spines.
Upon deletion of the STAT5 (show STAT5A Antibodies) response elements from the Socs2 promoter in mice, cytokine induction was abrogated, while basal activity remained intact. Our data suggest that promoter-bound STAT5 (show STAT5A Antibodies) modulates cytokine responses and enhancer-bound STAT5 (show STAT5A Antibodies) is mandatory for gene activation.
In a knockout mouse model, deficiency of SOCS2 was associated with decreased neuroinflammation and increased survival following HSV-1 infection, without significant effect on viral load. This result indicates that SOCS2 plays a major role in driving neuroinflammation and subsequent brain damage during HSV-1 encephalitis.
Our data show that absence of SOCS2 turns cardiomyocytes unresponsive to LIF (show LIF Antibodies)-induced [Ca(2 (show CA2 Antibodies)+)] raise, indicating that endogenous levels of SOCS2 are crucial for full activation of LIF (show LIF Antibodies) signaling in the heart.
Knockdown of SOCS2 makes mice less sensitive to multiple low dose streptozotocin.
Study provides an insight into the role of SOCS2 in modulating the immune response to Bovine herpesvirus 5 [BoHV-5]infection.
Data (including data from studies in knockout mice) suggest Socs2 regulates liver regeneration rate after partial hepatectomy, Ghr (growth hormone receptor (show GHR Antibodies)) level via ubiquitination/proteolysis, and serum Igf1 (insulin-like growth factor-1 (show IGF1 Antibodies)) level.
GH appears to act directly on the metatarsals of Socs2(-/-) mice, promoting growth via a mechanism that is independent of IGF-1 (show IGF1 Antibodies).
comparison of murine wt and Socs2(-/-) HSC (show FUT1 Antibodies) gene expression in response to 5-FU revealed a significant overlap with the molecular programs that correlate with SOCS2 expression in leukemias, particularly with the oncogenic pathways
hepatic growth hormone receptor (show GHR Antibodies) and suppressor of cytokine signaling (SOCS (show CISH Antibodies))2 messenger RNA expression appeared to be promptly and sensitively regulated by increased estradiol levels before ovulation of dairy heifers
relative amount of suppressors of cytokine signaling-2 (SOCS-2)messenger RNA increased after parturition
This gene encodes a member of the suppressor of cytokine signaling (SOCS) family. SOCS family members are cytokine-inducible negative regulators of cytokine receptor signaling via the Janus kinase/signal transducer and activation of transcription pathway (the JAK/STAT pathway). SOCS family proteins interact with major molecules of signaling complexes to block further signal transduction, in part, by proteasomal depletion of receptors or signal-transducing proteins via ubiquitination. The expression of this gene can be induced by a subset of cytokines, including erythropoietin, GM-CSF, IL10, interferon (IFN)-gamma and by cytokine receptors such as growth horomone receptor. The protein encoded by this gene interacts with the cytoplasmic domain of insulin-like growth factor-1 receptor (IGF1R) and is thought to be involved in the regulation of IGF1R mediated cell signaling. This gene has pseudogenes on chromosomes 20 and 22. Alternative splicing results in multiple transcript variants.
suppressor of cytokine signaling-2
, suppressor of cytokine signaling 2
, suppressor of cytokine signaling 2 variant 1
, STAT induced STAT inhibitor-2
, STAT-induced STAT inhibitor 2
, STAT-induced STAT inhibitor-2
, cytokine-inducible SH2 protein 2
, cytokine inducible SH2-containing protein 2
, suppressor of cytokine signalling 2